It was noted that increased levels of acrylamide and glycidamide hemoglobin in the women’s bloodstream was associated with a higher risk of breast cancer. At the same time among women with higher levels of acrylamide bound to the hemoglobin in their blood, there was a statistically significant increase in risk of estrogen receptor-positive breast cancer. Danish researchers found that higher levels of glycidamide hemoglobin in the blood was associated with a 63% higher risk of dying from all breast cancers, and more than double the risk of developing an estrogen receptor-positive tumor.
Discover
ALL about Acrylamide and breast cancer risks in ...
No comments:
Post a Comment